|
?:abstract
|
-
Background: The epidemic of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19), presents a significant and urgent threat to global health This alarming viral infection, declared as pandemic by the WHO in February 2020, has resulted millions of infected patients and thousands of deaths around the world In Morocco, despite the efforts made by the authorities, the SARS-CoV-2 continues to spread and constitutes a burden of morbidity and mortality The objective of this study is to describe clinical characteristics of COVID-19 Moroccan patients and to establish the relationship between specific clinical symptoms, namely ageusia and/or anosmia, with these characteristics Methods: We performed a descriptive, non-interventional cross-sectional study analyzing data from 108 patients admitted to the VINCI clinic, Casablanca (Morocco) The database includes 39 parameters including epidemiological characteristics, anthropometric measurements and biological analyzes Results: The average of age of the patients was 43 80 ± 15 75 years with a sex ratio of 1:1 The mean body mass index of the patients was 25 54 ± 4 63 Kg/m2 The majority of patients had, at least, one comorbidity and among 75% symptomatic patients, about 50% had, at least, three symptoms namely, fever (40 7%), cough (39 8%), myalgia (28 7%), and anosmia and/or ageusia (20 4%) From biological analyzes, we noticed lymphopenia and an elevated protein C reactive and lactate dehydrogenases levels in 24 1, 36 1, and 35 2% of patients, respectively A disturbance in liver function markers was observed in 15 7% of cases For the other hemostasis parameters, high levels of prothrombin and platelets were reported in 14 6 and 14 8% of patients, respectively Comparisons related to the presence of anosmia and/or ageusia did not show any difference for demographic and anthropometric characteristics, while a possibility of a significant difference was revealed for certain biological parameters, particularly the levels of lymphocytes, D-dimer and troponin Conclusion: This study provides significant findings that will be used not only to supplement previous studies carried out in Morocco in order to resume the epidemiological situation in comparison with other countries, but also to improve the quality of the diagnosis of COVID-19 patients by identifying all the symptoms of the disease and better understanding its clinical outcomes © Copyright © 2020 Benkirane, Heikel, Laamiri, Bouziani, Lahmam, Al-Jawaldeh, El Haloui, Ennibi, Akhtar-Khan, El Fahime, Obtel, Barkat and Aguenaou
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}